Category Archives: market data

Size and growth of Tissue Engineering and Cell Therapy in the U.S., Europe, Asia/Pacific and Rest of World

The global market for tissue engineering and cell therapy products is set to more than quadruple from 2009 to 2018. Products in cell therapy and tissue engineering include includes bioengineered products that are themselves cells or are actively stimulating cell growth or regeneration, products that often represent a combination of biotechnology, medical device and pharmaceutical [...]

Companies currently marketing cell therapy and tissue engineering in cancer

Cancer is a significant opportunity for the development of tissue engineering and cell therapies, but it is more than just an opportunity currently, since many companies are active and the market for cancer cell/tissue therapies already stands at nearly $500 million.  
Currently, OSI Pharmaceuticals has a commanding lead in this area, with its Tarceva being [...]

Clinical applications of medical/surgical sealants and glues

The applications of surgical sealants, glues and wound closure are many and are rapidly multiplying as more credible data is generated on each application and as physicians gain comfort in working with the products in routine clinical practice.
Below is a sample of surgical sealants, glues and wound closure applications by clinical area:

Source: MedMarket Diligence, LLC; [...]

Financing for medtech takes a dip in February

There was truly a stunning amount of VC investment in medical technology at the beginning of 2010, with the total funding of medtech in January at over $500 million.  (See link.)
Of course January's amount was way above average, but February's was indeed below average, creating a pretty big gap between the January investment of $514 million [...]

Wounds and wound management markets worldwide

(This is drawn in part from the Executive Summary of MedMarket Diligence's "Worldwide Wound Management Market, 2008-2017", Report #S247.)
The skin is our protection from the environment. Far from being just a physical barrier, the skin is a complex organ, protecting our bodies from chemical, biological and physical insult, keeping organs and tissues in their place, [...]

Orthopedic and skin tissue/cell therapy developments

With the initial markets for cell therapy and tissue engineering being best represented by clinical applications in orthopedics and skin/integumentary, a sampling of technologies at various states of development within each is worth considering for insights into likely near-term market impact.
Below are select technologies under development by companies in cell therapy and tissue engineering. While [...]

Tissue engineering and cell therapy basics

Cell Therapy is defined as a process whereby new cells are introduced into tissue as a method of treating disease; the process may or may not include gene therapy. Forms of cell therapy can include: transplantation of autologous (from the patient) or allogeneic (from a donor) stem cells , transplantation of mature, functional cells, application [...]

Drug-eluting stents market continues to rapidly evolve, globally

The global market for coronary stents is estimated to be in excess of $7 billion and projected to be growing at 6% per year. With the average age of citizens in developed countries increasing, there is an increased need to provide medical care to the average citizen. As such, an aging population translates into increasing [...]

Surgical sealants, glues and hemostats: developmental timelines

(Below is an excerpt from "Surgical Sealants, Glues and Wound Closure Worldwide Market, 2009-2013.")
Natural hemostats such as gelatin, collagen and thrombin were first developed as hemostatic agents, followed by mixes and fibrin sealants. More recently, companies have introduced synthetic sealants and hemostats that accelerate the process of blood clotting and provide a stronger seal that [...]

Cardiovascular and vascular cell therapy and tissue engineering

In the medical technology arena, the markets that draw the most attention (i.e., investment) are those that have historically had the biggest successes (i.e., revenues) due to their ability to have big impact on clinical outcomes.
Therefore, a clinical field beginning to draw much "attention" is in applications of cell therapy and tissue engineering for a [...]